atorvastatin has been researched along with dalteparin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hart, RG | 1 |
| Abedini, A; Amin, A; Bakhshandeh, H; Beigmohammadi, MT; Bikdeli, B; Dabbagh, A; Farrokhpour, M; Goldhaber, SZ; Gupta, A; Hadavand, N; Hajighasemi, A; Jamalkhani, S; Jimenez, D; Khalili, H; Kirtane, AJ; Krumholz, HM; Lip, GYH; Lookzadeh, S; Madhavan, MV; Maleki, M; Matin, S; Mohebbi, B; Monreal, M; Parhizgar, SE; Parikh, SA; Payandemehr, P; Piazza, G; Rashidi, F; Rezaeifar, P; Riahi, T; Sadeghian, S; Sadeghipour, P; Sezavar, H; Shahmirzaei, S; Sharif-Kashani, B; Tahamtan, O; Talasaz, AH; Yadollahzadeh, M | 1 |
1 review(s) available for atorvastatin and dalteparin
| Article | Year |
|---|---|
What's new in stroke? The top 10 studies of 2006-2008. Part II.
Topics: Anticoagulants; Atorvastatin; Drug Therapy, Combination; Enoxaparin; Evidence-Based Medicine; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Stroke | 2008 |
1 trial(s) available for atorvastatin and dalteparin
| Article | Year |
|---|---|
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Topics: Anticoagulants; Atorvastatin; COVID-19; COVID-19 Drug Treatment; Critical Illness; Double-Blind Method; Enoxaparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iran; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Thrombosis; Time Factors; Treatment Outcome; Venous Thromboembolism | 2020 |